Recent studies have shown that IKBKE is also overexpressed in ovarian cancer [9], endometrial carcinoma [10], prostate cancer [11], glioma [12, 13], renal clear cell carcinoma [14] and non-small cell lung cancer [15, 16]. This evidence concerns the gene IKBKE and ovarian carcinoma.